Bronchiectasis is a highly complex entity that can be very challenging to investigate and manage. Patients are diverse in their aetiology, symptoms, risk of complications and …
Objective To summarize the current understanding of diagnostic and postdiagnostic evaluation of common variable immunodeficiency (CVID). Data Sources PubMed Central …
LA Wall, EL Wisner, KS Gipson… - Frontiers in …, 2020 - frontiersin.org
Bronchiectasis, the presence of bronchial wall thickening with airway dilatation, is a particularly challenging complication of primary antibody deficiencies. While susceptibility to …
EM Matson, ML Abyazi, KA Bell, KM Hayes… - Frontiers in …, 2021 - frontiersin.org
Common variable immunodeficiency (CVID) is the most frequently diagnosed primary antibody deficiency. About half of CVID patients develop chronic non-infectious …
A Szczawinska-Poplonyk, E Schwartzmann… - European Journal of …, 2022 - Springer
Common variable immunodeficiency (CVID) is the most prevalent antibody deficiency, characterized by remarkable genetic, immunological, and clinical heterogeneity. The …
F Dhalla, DJM Lochlainn, H Chapel… - Frontiers in …, 2020 - frontiersin.org
Interstitial lung disease (ILD) is an important non-infectious complication in several primary immune deficiencies. In common variable immune deficiency (CVID) it is associated with …
Interstitial lung disease (ILD) is a common complication in patients with common variable immunodeficiency (CVID) and often associated with other features, such as bronchiectasis …
ML Abyazi, KA Bell, G Gyimesi, TS Baker… - Journal of Allergy and …, 2022 - Elsevier
Background Noninfectious complications are the greatest cause of morbidity and mortality in common variable immunodeficiency (CVID), but their pathogenesis remains poorly defined …
One of the complications of common variable immunodeficiency (CVID) is the development of lymphoid malignancy. In this retrospective, single‐center study of 647 CVID subjects …